Home > Medicine & Health Science textbooks > Medical specialties, branches of medicine > Pathology > FBI-1 and Ampk in Choriocarcinoma Cells: (English)
FBI-1 and Ampk in Choriocarcinoma Cells: (English)

FBI-1 and Ampk in Choriocarcinoma Cells: (English)

          
5
4
3
2
1

Out of Stock


Premium quality
Premium quality
Bookswagon upholds the quality by delivering untarnished books. Quality, services and satisfaction are everything for us!
Easy Return
Easy return
Not satisfied with this product! Keep it in original condition and packaging to avail easy return policy.
Certified product
Certified product
First impression is the last impression! Address the book’s certification page, ISBN, publisher’s name, copyright page and print quality.
Secure Checkout
Secure checkout
Security at its finest! Login, browse, purchase and pay, every step is safe and secured.
Money back guarantee
Money-back guarantee:
It’s all about customers! For any kind of bad experience with the product, get your actual amount back after returning the product.
On time delivery
On-time delivery
At your doorstep on time! Get this book delivered without any delay.
Notify me when this book is in stock
Add to Wishlist
X

About the Book

This dissertation, "FBI-1 and AMPK in Choriocarcinoma Cells" by Kwong-shing, Tsang, 曾廣成, was obtained from The University of Hong Kong (Pokfulam, Hong Kong) and is being sold pursuant to Creative Commons: Attribution 3.0 Hong Kong License. The content of this dissertation has not been altered in any way. We have altered the formatting in order to facilitate the ease of printing and reading of the dissertation. All rights not granted by the above license are retained by the author. Abstract: Choriocarcinoma is a rare and highly aggressive tumorwhich belongs to the gestational trophoblastic diseases (GTD). It can be originated from either gestational or non-gestational origins. Choriocarcinoma is characterized by biphasic pattern and is composed of a mixed population of mononuclear cytotrophoblasts and multinucleated syncytotrophoblasts. Because of its low prevalence, information on the biology of choriocarcinoma is still insufficient. FBI-1 is an oncogenic transcription factor that is found to be overexpressed in various cancers. In our previous study, overexpression of FBI-1 in gestational choriocarcinoma cell lines, JEG-3 and JAR, were found. FBI-1 affects cell survival through regulating apoptosis and modulating cell motility in choriocarcinoma cells. However, the underlying mechanisms on how FBI-1affectscellular functions is largely unknown. AMPK is a master regulator in metabolic pathways and helps cells to maintain energy homeostasis in response to stressful conditions. Dysregulation on AMPK upsets the balance in metabolism that may play a role in the pathogenesis of cancers. Besides, AMPK is strongly associated with Warburg effect which is considered as a hallmark of cancer. In this study, we aim to investigate the relation between FBI-1 and AMPK in choriocarcinoma. Normal trophoblast cell lines HTR-8/SVneo and TEV-1as well as choriocarcinoma cell lines JAR, BeWo and JEG-3 were used. Levels of mRNA and protein expressions were evaluated by qRT-PCR and western blot respectively. In choriocarcinoma cell lines, relative lower levels of both AMPKα1 andα2 mRNA and protein were demonstrated when compared with the normal trophoblast cells lines. After knock down of FBI-1 in choriocarcinoma cell lines, JEG-3 and JAR, the expression of AMPK α1 but not theα2 subunit was suppressed. The expressions of a panel of glycolysis-related genes, including hexokinase II (HK2), phosphoglycerate kinase 1 (PGK1), lactate dehydrogenase A (LDHA), pyruvate kinase muscle isozymeM2 (PKM2), aldolase C (ALDOC) and glucose transporter 1(GLUT1), were examined in this study. It was found that the expressions of most of these genes were unaffected. ALDOC mRNA and HK2 protein expression was found to decrease in choriocarcinoma cells with FBI-1 knockdown, suggesting that glycolytic pathway was affected by FBI-1. These results tend to indicate that AMPK may cooperate with FBI-1 in choriocarcinoma cells to gain survival advantages through modulation of glycolysis although further study is needed. Subjects: Choriocarcinoma Transcription factors Protein kinases


Best Sellers


Product Details
  • ISBN-13: 9781361017067
  • Publisher: Open Dissertation Press
  • Publisher Imprint: Open Dissertation Press
  • Height: 279 mm
  • No of Pages: 104
  • Spine Width: 8 mm
  • Width: 216 mm
  • ISBN-10: 1361017066
  • Publisher Date: 26 Jan 2017
  • Binding: Hardback
  • Language: English
  • Series Title: English
  • Weight: 540 gr


Similar Products

How would you rate your experience shopping for books on Bookswagon?

Add Photo
Add Photo

Customer Reviews

REVIEWS           
Click Here To Be The First to Review this Product
FBI-1 and Ampk in Choriocarcinoma Cells: (English)
Open Dissertation Press -
FBI-1 and Ampk in Choriocarcinoma Cells: (English)
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

FBI-1 and Ampk in Choriocarcinoma Cells: (English)

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book
    Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals


    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!
    ASK VIDYA